Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

This study has been terminated.
(Insufficient recruitment)
Sponsor:
Information provided by (Responsible Party):
Alberto Sanchez-Fueyo, Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT01445236
First received: September 29, 2011
Last updated: December 19, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)